Debt / revenue moved 5392 bp lower
Debt / revenue changed -5392 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt / revenue changed -5392 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +49 basis points from the comparable as-filed period.
Total assets changed -8.8% from the comparable as-filed period.
Capex / revenue changed +49 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed -2.9% from the comparable as-filed period.
Research & development changed -9.0% from the comparable as-filed period.
Capital expenditure changed +12.6% from the comparable as-filed period.
Selling, general & administrative changed -9.1% from the comparable as-filed period.
Gross profit changed -0.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -3.5% from the comparable as-filed period.
R&D / revenue changed -33 basis points from the comparable as-filed period.
Working capital / assets changed +316 basis points from the comparable as-filed period.
Current long-term debt changed -33.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Debt / equity changed +286 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed +24.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +52 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +0.3% from the comparable as-filed period.
Working capital changed +9.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +12.7% from the comparable as-filed period.
Debt / revenue changed -134 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +35 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed -3.2% from the comparable as-filed period.
Current assets changed +4.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Reported total debt changed -1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Noncurrent long-term debt changed -1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross debt changed -1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Inventory changed +1.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Debt / assets changed +63 basis points from the comparable as-filed period.
Research & development changed -3.3% from the comparable as-filed period.
Current ratio changed +5.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed -2.4% from the comparable as-filed period.
Current liabilities changed -0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +4.4% from the comparable as-filed period.
R&D / revenue changed -18 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.